Adult Neurofibromatosis Type 1 (NF1) and Schwannomatosis Clinic
The UCSF Adult Neurofibromatosis Type 1 (NF1) and Schwannomatosis Clinic brings together specialists with expertise in treating all kinds of NF1 and schwannomatosis, including neurofibromatosis type 2. Our mission is to provide lifelong care for patients with these complex genetic conditions, which cause noncancerous tumors to form in the nervous system. We work closely with the pediatric NF1 clinic to seamlessly transition patients to adult care.
Our goal is to bring our patients the best possible outcomes and quality of life using the latest technologies and treatments. We provide access to clinical trials (studies of promising new therapies) and are part of the Neurofibromatosis Clinical Trials Consortium, a collaboration among clinical centers that share the goal of improving treatments through clinical trials. We are also part of the UCSF Brain Tumor Center, which has a program that connects patients' caregivers and family members with the resources and support they need.
The Children's Tumor Foundation has recognized us as an NF1 and schwannomatosis comprehensive care center for patients with these conditions.
Our locations (1)
Our team
Clinical trials
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Will be measured by the number of progressions or deaths within 2 years of enrollment for the cohort treated with whole ventricular + spinal canal irradiation (WVSCI). The final analysis will include an exact binomial confidence i...
Recruiting
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for Primary C...
We will estimate the difference in mean Cogstate composite Z score slopes (reflecting change in Cogstate composite Z scores from baseline to 12 months post baseline taking into account measurements at those time points as well as ...
Recruiting
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromato...
EFS is defined as time from randomization to the first occurrence of any of the following events: clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death from any cause. Patients who a...
Recruiting
Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
Patients that received our intervention will be evaluated post operatively for regular standard of care six weeks post-operatively. During visual evaluation, the PI of this study will determine post-operative visual field and visu...
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Gli...
The Kaplan-Meier method will be used to estimate EFS which is defined as the interval from randomization to first occurrence of clinical or radiographic disease progression, disease recurrence, second malignant neoplasm, or death ...
Recruiting
ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery
The investigators will evaluate the percentage of participants that present with decreased of visual acuity and any modality of visual field defect after the surgery. Postoperative visual acuity and visual field testing will be pe...
Recruiting
Awards & recognition
-
Among the top hospitals in the nation
-
Best in Northern California and No. 7 in the nation for cancer care
-
Best in the West and No. 3 in the nation for neurology & neurosurgery
-
in the U.S. for number of brain tumor patients treated
Support services
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes